Keyphrases
Fibrin
100%
Glioblastoma Therapy
100%
Chimeric Antigen Receptor T-cell Therapy
66%
Chimeric Antigen Receptor T Cells (CAR-T)
66%
Glioblastoma
50%
Biomaterials
33%
Co-delivery
33%
Glioblastoma multiforme
33%
Tumor Microenvironment
33%
Drug Delivery
22%
Cell Therapy
22%
Antitumor Efficacy
22%
Hard to Treat
16%
Blood-brain Barrier
16%
Marina
16%
Oral Communication Skills
16%
Avastin
16%
Gel Carrier
16%
Antiangiogenic Agents
16%
Tumor Targeting
16%
Advanced Delivery
16%
Tumor Resection
16%
Nanobiotechnology
16%
Career Transition
16%
Faculty Positions
16%
T Cell Exhaustion
16%
Cell Tumor
16%
Nanoformulation
16%
Technical Writing
16%
Toll-like Receptor 7 (TLR7)
16%
Immune Defense
16%
Therapy Approaches
16%
Glioma Model
16%
Regional Delivery
16%
Glioblastoma Cells
16%
Immune Engineering
16%
Treatment Combination
16%
Targeted Therapy
11%
Career Goals
11%
Mentored Research
11%
School of Medicine
11%
Specific Intent
11%
Cancer Center
11%
Oncology
11%
Effective Therapy
11%
Delivery System
11%
Pharmacy School
11%
Interdisciplinary Research
11%
Medicine and Dentistry
Glioblastoma
100%
Chimeric Antigen Receptor T-Cell Immunotherapy
66%
Chimeric Antigen Receptor T-Cell
50%
Biocompatible Material
25%
Tumor Microenvironment
25%
Malignant Neoplasm
25%
Cell Therapy
16%
Neoplasm
16%
Bevacizumab
12%
Blood Brain Barrier
12%
Cancer Surgery
12%
Oral Communication
12%
Communication Skill
12%
Toll Like Receptor 7
12%
Angiogenesis Inhibitor
12%
Targeted Therapy
8%
T Cell
8%
Medicine
8%
Oncology
8%
Cytokine
8%
Pharmacology, Toxicology and Pharmaceutical Science
Glioblastoma
100%
Chimeric Antigen Receptor
100%
Malignant Neoplasm
25%
Tumor Microenvironment
25%
Neoplasm
25%
Biomaterial
25%
Bevacizumab
12%
Angiogenesis Inhibitor
12%
Blood-Brain Barrier
12%
Toll Like Receptor 7
12%
Cytokine
8%